USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Omron Healthcare Co., Ltd.

USPTO PatentsView assignee record - 499 granted patents across 71 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

499
Total patents granted
71
CPC technology areas
7.0
Avg claims per patent
+51%
5-year filing velocity

The verdict

Omron holds 499 US patents across 71 technology areas, rank #902 of 50,000 tracked assignees.

#902
of 50,000 US assignees by volume
Top 4%
by Innovation Score (59.8/100)
7.0
avg claims per patent
+51%
filing velocity, last 5 yrs

Portfolio overview

Omron Healthcare Co., Ltd. has been granted 499 US utility patents between 2015 and 2025, placing Omron Healthcare Co., Ltd. at rank #902 across all assignees tracked by PlainPatent. This portfolio spans 71 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.0 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Omron Healthcare Co., Ltd. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Omron sits between China Petroleum & Chemical Corporation (500 patents, rank #898) and Wilus Institute OF Standards AND Technology Inc. (496 patents, rank #906) - the closest US assignees by grant volume. The composite Innovation Score of 59.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 300 grants, compared with 199 in the 2015–2019 window, a +51% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Omron Healthcare Co., Ltd.'s 7.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 71 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Omron Healthcare Co., Ltd. against peers pursuing similar technology classes.

Who files at Omron's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Omron holds 499 patents at rank #902, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Omron

By rank, the assignees closest to #902 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Omron's primary technology class.

Omron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

60 Top 4% higher than 96% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

020406080 20152016201720182019202020212022202320242025 18
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Omron Healthcare Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 55 11.0%
2016 46 9.2%
2017 24 4.8%
2018 39 7.8%
2019 35 7.0%
2020 48 9.6%
2021 51 10.2%
2022 68 13.6%
2023 48 9.6%
2024 67 13.4%
2025 18 3.6%

Which technologies does Omron Healthcare Co., Ltd. patent most?

Top 15 of 71 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Simple
Velocity Accelerating

Where it ranks

Overall rank by patents

#902

Across all tracked assignees

Innovation Score

59.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Omron Healthcare Co., Ltd. hold?
Omron Healthcare Co., Ltd. holds 499 US granted patents filed between 2015 and 2025, spanning 71 technology areas.
What is Omron Healthcare Co., Ltd.'s Innovation Score?
Omron Healthcare Co., Ltd. has an Innovation Score of 59.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Omron Healthcare Co., Ltd. focus on?
Omron Healthcare Co., Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 296 patents. The company has filed patents in 71 CPC subclasses total.
Is Omron Healthcare Co., Ltd.'s patent filing rate increasing or decreasing?
Omron Healthcare Co., Ltd.'s recent filing velocity is +51% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Omron Healthcare Co., Ltd.'s patents?
Omron Healthcare Co., Ltd.'s patents average 7.0 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Omron Healthcare Co., Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Omron's 499 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Omron ranks #902 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.